1-4 of 4
Denise Kohn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Second-Line Bosutinib Is Effective and Feasible in Patients Failing Second Generation TKI (2G-TKI) in Chronic Phase Chronic Myeloid Leukemia (CML) - an Analysis of a Subcohort of the Bodo Trial (CML-VII-study of the German CML Study Group)

Susanne Isfort, Kirsi Manz, Lino L. Teichmann, Martina Crysandt, Andreas Burchert, Andreas Hochhaus, Susanne Saussele, Alexander Kiani, Joachim R. Goethert, Thomas Illmer, Philippe Schafhausen, Haifa Kathrin Al-Ali, Frank Stegelmann, Mathias Hänel, Tim Pfeiffer, Aristoteles Giagounidis, Georg-Nikolaus Franke, Steffen Koschmieder, Alice Fabarius, Thomas Ernst, Mareille Warnken-Uhlich, Denise Kohn, Markus Pfirrmann, Dominik Wolf, Tim H. H. Brummendorf
Journal: Blood
Blood (2024) 144 (Supplement 1): 1766.
https://doi.org/10.1182/blood-2024-208687
Published: 2024
Journal Articles

Treatment Free Remission after Nilotinib Plus Peg-Interferon Alpha Induction and Peg-Interferon Alpha Maintenance Therapy for Newly Diagnosed Chronic Myeloid Leukemia Patients; The Tiger Trial

Andreas Hochhaus, Andreas Burchert, Susanne Saussele, Gabriela M Baerlocher, Jiří Mayer, Tim H. Brümmendorf, Paul La Rosée, Dominik Heim, Stefan W. Krause, Philipp le Coutre, Jenny Rinke, Thoralf Lange, Alice Fabarius, Marcel Lorch, Mathias Hanel, Frank Stegelmann, Georg-Nikolaus Franke, Markus P. Radsak, Volker Kunzmann, Daniela Zackova, Danny Himsel, Denise Kohn, Thomas Lang, Rüdiger Hehlmann, Christian Fabisch, Thomas Ernst, Markus Pfirrmann
Journal: Blood
Blood (2023) 142 (Supplement 1): 446.
https://doi.org/10.1182/blood-2023-182792
Published: 2023
Journal Articles

Health-Related Quality of Life of CML Patients Under 2nd or 3rd Line Bosutinib Is Not Impaired Significantly By Gastrointestinal Toxicity (GI Tox) but Influenced By Sex - Results from a Subanalysis of the Bosutinib Dose Optimization (BODO) Study (CML-VII) Trial of the German CML Study Group

Susanne Isfort, Dominik Wolf, Lino L. Teichmann, Martina Crysandt, Andreas Burchert, Andreas Hochhaus, Susanne Saussele, Alexander Kiani, Joachim R Göthert, Thomas Illmer, Philippe Schafhausen, Mareille Warnken-Uhlich, Uta Wolber, Denise Kohn, Kirsi Manz, Markus Pfirrmann, Tim H.H. Brummendorf
Journal: Blood
Blood (2022) 140 (Supplement 1): 12194–12196.
https://doi.org/10.1182/blood-2022-164607
Published: 2022
Journal Articles

Step-in Dosing in the Bosutinib Dose Optimization Study (BODO) Failed to Reduce Gastrointestinal (GI) Toxicity in Patients Failing Second Generation TKI (2G-TKI) in Chronic Phase Chronic Myeloid Leukemia (CML) but Suggests Promising Molecular Response

Susanne Isfort, Dominik Wolf, Lino L. Teichmann, Martina Crysandt, Andreas Burchert, Andreas Hochhaus, Susanne Saussele, Alexander Kiani, Joachim R. Göthert, Thomas Illmer, Philippe Schafhausen, Mareille Warnken-Uhlich, Uta Wolber, Denise Kohn, Kirsi Manz, Markus Pfirrmann, Tim H Brümmendorf
Journal: Blood
Blood (2021) 138 (Supplement 1): 3608.
https://doi.org/10.1182/blood-2021-151240
Published: 2021